117 related articles for article (PubMed ID: 9989837)
1. Linkage between melanocytic tumor development and early burst of Ret protein expression for tolerance induction in metallothionein-I/ret transgenic mouse lines.
Kato M; Liu W; Akhand AA; Dai Y; Ohbayashi M; Tuzuki T; Suzuki H; Isobe K; Takahashi M; Nakashima I
Oncogene; 1999 Jan; 18(3):837-42. PubMed ID: 9989837
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of MMP-9 and TIMP-2 expression in malignant melanoma developed in metallothionein/RET transgenic mice.
Asai M; Kato M; Asai N; Iwashita T; Murakami H; Kawai K; Nakashima I; Takahashi M
Jpn J Cancer Res; 1999 Jan; 90(1):86-92. PubMed ID: 10076570
[TBL] [Abstract][Full Text] [Related]
3. Proliferation and neoplastic transformation of pigment cells in metallothionein/ret transgenic mice.
Takahashi M; Iwamoto T; Nakashima I
Pigment Cell Res; 1992 Nov; 5(5 Pt 2):344-7. PubMed ID: 1292018
[TBL] [Abstract][Full Text] [Related]
4. T-cell-immunity-based inhibitory effects of orally administered herbal medicine juzen-taiho-to on the growth of primarily developed melanocytic tumors in RET-transgenic mice.
Dai Y; Kato M; Takeda K; Kawamoto Y; Akhand AA; Hossain K; Suzuki H; Nakashima I
J Invest Dermatol; 2001 Sep; 117(3):694-701. PubMed ID: 11564179
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a malignant melanocytic tumor cell line expressing the ret oncogene.
Taniguchi M; Iwamoto T; Nakashima I; Nakayama A; Ohbayashi M; Matsuyama M; Takahashi M
Oncogene; 1992 Aug; 7(8):1491-6. PubMed ID: 1630812
[TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma in a transgenic mouse carrying a metallothionein/ret fusion gene.
Iwamoto T; Taniguchi M; Wajjwalku W; Nakashima I; Takahashi M
Br J Cancer; 1993 Mar; 67(3):504-7. PubMed ID: 8439501
[TBL] [Abstract][Full Text] [Related]
7. The ret oncogene can induce melanogenesis and melanocyte development in Wv/Wv mice.
Iwamoto T; Takahashi M; Ohbayashi M; Nakashima I
Exp Cell Res; 1992 Jun; 200(2):410-5. PubMed ID: 1374037
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
Kawai K; Iwashita T; Murakami H; Hiraiwa N; Yoshiki A; Kusakabe M; Ono K; Iida K; Nakayama A; Takahashi M
Cancer Res; 2000 Sep; 60(18):5254-60. PubMed ID: 11016655
[TBL] [Abstract][Full Text] [Related]
9. Mapping of melanoma modifier loci in RET transgenic mice.
Dragani TA; Peissel B; Zanesi N; Aloisi A; Dai Y; Kato M; Suzuki H; Nakashima I
Jpn J Cancer Res; 2000 Nov; 91(11):1142-7. PubMed ID: 11092979
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mouse model for skin malignant melanoma.
Kato M; Takahashi M; Akhand AA; Liu W; Dai Y; Shimizu S; Iwamoto T; Suzuki H; Nakashima I
Oncogene; 1998 Oct; 17(14):1885-8. PubMed ID: 9778055
[TBL] [Abstract][Full Text] [Related]
11. RET tyrosine kinase enhances hair growth in association with promotion of melanogenesis.
Kato M; Takeda K; Kawamoto Y; Tsuzuki T; Dai Y; Nakayama S; Toriyama K; Tamada Y; Takahashi M; Nakashima I
Oncogene; 2001 Nov; 20(51):7536-41. PubMed ID: 11709725
[TBL] [Abstract][Full Text] [Related]
12. A thyroid tumor-specific antigen formed by the fusion of two self proteins.
Powell DJ; Eisenlohr LC; Rothstein JL
J Immunol; 2003 Jan; 170(2):861-9. PubMed ID: 12517951
[TBL] [Abstract][Full Text] [Related]
13. c-Kit-targeting immunotherapy for hereditary melanoma in a mouse model.
Kato M; Takeda K; Kawamoto Y; Tsuzuki T; Hossain K; Tamakoshi A; Kunisada T; Kambayashi Y; Ogino K; Suzuki H; Takahashi M; Nakashima I
Cancer Res; 2004 Feb; 64(3):801-6. PubMed ID: 14871802
[TBL] [Abstract][Full Text] [Related]
14. Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues.
Tsuzuki T; Takahashi M; Asai N; Iwashita T; Matsuyama M; Asai J
Oncogene; 1995 Jan; 10(1):191-8. PubMed ID: 7824273
[TBL] [Abstract][Full Text] [Related]
15. Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice.
Acton DS; Velthuyzen D; Lips CJ; Höppener JW
Oncogene; 2000 Jun; 19(27):3121-5. PubMed ID: 10871866
[TBL] [Abstract][Full Text] [Related]
16. Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene.
Iwamoto T; Takahashi M; Ito M; Hamatani K; Ohbayashi M; Wajjwalku W; Isobe K; Nakashima I
EMBO J; 1991 Nov; 10(11):3167-75. PubMed ID: 1915289
[TBL] [Abstract][Full Text] [Related]
17. Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene.
Portella G; Salvatore D; Botti G; Cerrato A; Zhang L; Mineo A; Chiappetta G; Santelli G; Pozzi L; Vecchio G; Fusco A; Santoro M
Oncogene; 1996 Nov; 13(9):2021-6. PubMed ID: 8934550
[TBL] [Abstract][Full Text] [Related]
18. RET receptor expression in thyroid follicular epithelial cell-derived tumors.
Bunone G; Uggeri M; Mondellini P; Pierotti MA; Bongarzone I
Cancer Res; 2000 Jun; 60(11):2845-9. PubMed ID: 10850426
[TBL] [Abstract][Full Text] [Related]
19. Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation.
Michiels FM; Chappuis S; Caillou B; Pasini A; Talbot M; Monier R; Lenoir GM; Feunteun J; Billaud M
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3330-5. PubMed ID: 9096393
[TBL] [Abstract][Full Text] [Related]
20. Induction of RET proto-oncogene expression in neuroblastoma cells precedes neuronal differentiation and is not mediated by protein synthesis.
Bunone G; Borrello MG; Picetti R; Bongarzone I; Peverali FA; de Franciscis V; Della Valle G; Pierotti MA
Exp Cell Res; 1995 Mar; 217(1):92-9. PubMed ID: 7867726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
